Joshua Weber Todd MD
Echocardiography, Interventional Cardiology, Nuclear Cardiology
Interventional Cardiologist at Knoxville Heart Group
Join to View Full Profile
1819 Clinch AveSuite 108Knoxville, TN 37916
Phone+1 865-546-5111
Dr. Todd is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of North Carolina HospitalsFellowship, Interventional Cardiology, 2010 - 2011- University of North Carolina HospitalsFellowship, Cardiovascular Disease, 2007 - 2010
Baylor College of MedicineResidency, Internal Medicine, 2004 - 2007
Medical College of Georgia at Augusta UniversityClass of 2004
Certifications & Licensure
TN State Medical License 2011 - 2026
NC State Medical License 2007 - 2012
TX State Medical License 2006 - 2007
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Fellow The Society of Cardiovascular Angiography and Interventions, 2015
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 36 citationsVasopressors independently associated with mortality in acute myocardial infarction and cardiogenic shock.Mir B Basir, Alejandro Lemor, Sarah Gorgis, Angela M. Taylor, Behnam Tehrani
Catheterization and Cardiovascular Interventions. 2021-08-03 - 3 citationsImpact of Age in Acute Myocardial Infarction Cardiogenic Shock. Insights from the National Cardiogenic Shock InitiativeAlejandro Lemor, Mir B Basir, Sarah Gorgis, Josh Todd, Steve Marso
Critical Pathways in Cardiology. 2021-02-17 - 316 citationsImproved Outcomes Associated with the use of Shock Protocols: Updates from the National Cardiogenic Shock InitiativeMir B Basir, Navin K. Kapur, Kirit Patel, Murad A Salam, Theodore Schreiber
Catheterization and Cardiovascular Interventions. 2019-06-01
Press Mentions
ARMGO Pharma Publishes Positive Phase 1b Trial Results of Rycal® ARM210 for the Treatment of Ryanodine Receptor 1 Related MyopathiesFebruary 13th, 2024
Professional Memberships
- Member
External Links
- Knoxville Heart Grouphttp://www.knoxheart.org
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
